The human immunodeficiency virus-infected traveler

Clinical Infectious Diseases

Volumn 31, Issue 6, 2000, Pages 1403-1408

  Castelli, Francesco ^a   Patroni, Andrea ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BACTERIAL VACCINE; VIRUS VACCINE;

AIDS RELATED COMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION CONTROL; REVIEW; SAFE SEX; TRAVEL; VACCINATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; BACTERIAL VACCINES; COMMUNICABLE DISEASE CONTROL; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; SAFE SEX; TRAVEL; VACCINATION; VIRAL VACCINES;

EID: 0034571840     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/317488     Document Type: Article

References (19)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatients Study Investigators. N Engl J Med 1998;338:853-60.
2. Kemper CA, Linett A, Kane C, Deresinsky SC. Frequency of travel of adults infected with HIV. J Travel Med 1995;2:85-8.
3. Simons FM, Cobelens FG, Danner SA. Common health problems in HIV-infected travelers to the sub-tropics. J Travel Med 1999;6:71-5.
4. AIDS and HIV in Scotland, 1996: a summary. SCIEH Weekly Report, 1997;31:33.
5. Wilson ME, Fordham von Reyn F, Finberg HV. Infections in HIV infected travelers: risk and prevention. Ann Intern Med 1991;114:582-92.
6. World Health Organization. Global AIDS surveillance 1999. Wkly Epidemiol Record 1999;74:401-8.
7. Gruenewald R, Blum S, Chan J. Relationship between human immunodeficiency virus infection and salmonellosis in 20- to 59-year-old residents of New York City. Clin Infect Dis 1994;18:358-63.
8. Okenga J, Tillmann HL, Trautwein C, Stoll M, Manns MP, Schmidt RE. Hepatitis B and C in HIV infected patients. J Hepatol 1997;27:18-24.
9. Vento S, Garofano T, Renzini C, et al. Fulminant hepatitis associated with HAV superinfection. N Engl J Med 1998;338:286-90.
10. Thurn JR, Henry K. Influenza A pneumonitis in a patient infected with the human immunodeficiency virus. Chest 1989;95:807-10.
11. Van Compel A, Kozarsky P, Colebunders R. Adult travelers with HIV infection. J Travel Med 1997;4:136-43.
12. Goujon C, Tohr M, Feuillie V, Coulaud JP, Dupont B, Sansonetti P. Good tolerance and efficacy of yellow fever vaccine among carriers of human immunodeficiency virus. J Travel Med 1995;2:145.
13. Fuller JD, Craven DE, Steger KA, Cox N, Heeren TC, Chernoff D. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis 1999;28:541-7.
14. Santagostino E, Gringeri A, Rocino A, Zanetti A, De Biasi R, Mannucci PM. Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophiliac patients. Thromb Haemost 1994;72:508-10.
15. Tayal SC, Sankar KM. Impaired response to recombinant hepatitis B vaccine in asymptomatic HIV-infected individuals. AIDS 1994;8:558-9.
16. Gebo KA, Moore RD, Keruly JC, Chaisson RE. Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients. J Infect Dis 1996;173:857-62.
17. O'Brien W, Grovit-Ferbas K, Namazi A, et al. Human immunodeficiency virus type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995;86:1082-9.
18. + cells. AIDS Res Hum Retroviruses 2000;16:19-25.
19. Maserati R, Villani P, Barasolo G, Mongiovetti M, Regazzi BM. Influenza immunization and indinavir pharmacokinetics. Scand J Infect Dis 2000;32:449-50.